Medicare Enrolled
Dr. Evan Lang, MD
Hematology & Oncology · Hamilton, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lang
Dr. Evan Lang is a hematology & oncology specialist in Hamilton, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lang performed 52,481 Medicare services across 2,898 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lang received a total of $48,732 from 48 pharmaceutical and/or device companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in OH
$48,732 industry payments
Medicare Practice Summary
Medicare Utilization ↗52,481
Medicare services
Top 10% in OH for hematology & oncology
2,898
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,624 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
15,810 | $0 | $6 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
9,000 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
4,350 | $0 | $6 |
| Denosumab injection (Prolia/Xgeva) | 3,960 | $18 | $70 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
3,610 | $6 | $30 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,560 | $6 | $55 |
| Iron infusion (Monoferric) | 2,000 | $16 | $78 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,988 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 1,420 | $0 | $25 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,019 | $8 | $35 |
| Anti-nausea injection (Aloxi/palonosetron) | 650 | $1 | $122 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
579 | $60 | $205 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
407 | $10 | $62 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
378 | $10 | $93 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
365 | $89 | $305 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
340 | $92 | $686 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
232 | $11 | $105 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
204 | $13 | $58 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
199 | $21 | $152 |
| Iron level test | 195 | $6 | $26 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
195 | $9 | $34 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
170 | $2 | $300 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
152 | $44 | $304 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
140 | $9 | $54 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
136 | $4 | $29 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
115 | $0 | $5 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
104 | $6 | $462 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
96 | $1 | $7 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
90 | $15 | $74 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
85 | $1 | $19 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
82 | $47 | $334 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
68 | $61 | $210 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
66 | $14 | $71 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
63 | $133 | $585 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
59 | $37 | $125 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
51 | $6 | $30 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
51 | $22 | $141 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
51 | $90 | $300 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
48 | $21 | $156 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
48 | $15 | $111 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
46 | $14 | $97 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
44 | $113 | $475 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
37 | $130 | $410 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
34 | $76 | $310 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
32 | $16 | $78 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
31 | $19 | $96 |
| New patient office visit, complex (60-74 min) | 27 | $159 | $590 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
25 | $2 | $19 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
19 | $124 | $523 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
19 | $24 | $249 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
16 | $9 | $73 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
15 | $7 | $28 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
35.6% high complexity
56.6% medium
7.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$48,732
Total received (2018-2024)
Avg $6,962/year across 7 years
Top 14% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
236
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$32,745 (67.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$11,966 (24.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,020 (8.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,353
2023
$2,232
2022
$7,231
2021
$6,613
2020
$8,576
2019
$16,342
2018
$1,385
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,628
Bayer Healthcare Pharmaceuticals Inc.
$1,140
GlaxoSmithKline, LLC.
$668
BeiGene USA, Inc.
$302
Gilead Sciences, Inc.
$103
Eisai Inc.
$69
Novartis Pharmaceuticals Corporation
$69
Incyte Corporation
$63
ABBVIE INC.
$58
Daiichi Sankyo Inc.
$47
Stemline Therapeutics Inc.
$46
Takeda Pharmaceuticals U.S.A., Inc.
$34
PFIZER INC.
$31
Merck Sharp & Dohme LLC
$29
GENZYME CORPORATION
$27
JAZZ PHARMACEUTICALS INC.
$23
Legend Biotech USA Inc.
$17
Top 3 companies account for 85.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$9,418
Bayer HealthCare Pharmaceuticals Inc.
$7,097
AstraZeneca Pharmaceuticals LP
$5,528
Blueprint Medicines Corporation
$4,169
G1 Therapeutics, Inc.
$3,000
BeiGene USA, Inc.
$2,177
E.R. Squibb & Sons, L.L.C.
$1,960
Celgene Corporation
$1,557
Janssen Biotech, Inc.
$1,358
Exelixis Inc.
$1,338
JAZZ PHARMACEUTICALS INC.
$1,283
ARRAY BIOPHARMA INC
$1,274
Bayer Healthcare Pharmaceuticals Inc.
$1,158
BeiGene, Ltd.
$975
Amgen Inc.
$865
Agios Pharmaceuticals, Inc.
$681
GlaxoSmithKline, LLC.
$668
Daiichi Sankyo Inc.
$628
Pharmacyclics LLC, An AbbVie Company
$422
Genentech USA, Inc.
$312
Takeda Pharmaceuticals U.S.A., Inc.
$236
Incyte Corporation
$230
Merck Sharp & Dohme Corporation
$229
Astellas Pharma US Inc
$195
Seagen Inc.
$150
SANOFI-AVENTIS U.S. LLC
$148
Sirtex Medical Inc
$143
Pharmacyclics LLC, an AbbVie Company
$141
GENZYME CORPORATION
$140
TESARO, Inc.
$125
Clovis Oncology, Inc.
$119
Gilead Sciences, Inc.
$115
Progenics Pharmaceuticals, Inc.
$115
Eisai Inc.
$106
AbbVie, Inc.
$100
Epizyme, Inc.,
$94
Stemline Therapeutics Inc.
$66
PFIZER INC.
$64
ABBVIE INC.
$58
Merck Sharp & Dohme LLC
$53
Rigel Pharmaceuticals, Inc.
$52
Janssen Pharmaceuticals, Inc
$41
AVEO Pharmaceuticals, Inc.
$40
Kyowa Kirin, Inc.
$26
Lilly USA, LLC
$23
Genmab U.S., Inc.
$21
ADC Therapeutics America, Inc.
$17
Legend Biotech USA Inc.
$17
Top 3 companies account for 45.2% of all-time payments
Associated products mentioned in payments ›
AYVAKIT · BRAFTOVI · BRUKINSA · COSELA · Cabometyx · Creon · DARZALEX · ELIQUIS · ELITEK · EMPLICITI · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · NINLARO · Nplate · OJJAARA · OPDIVO · Orserdu · PROMACTA · PYLARIFY · PYRUKYND · Pomalyst · RETEVMO · Rezlidhia · Rituxan · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SPRYCEL · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TUKYSA · Tavalisse · Trodelvy · VENCLEXTA · Vitrakvi · XARELTO · Xofigo · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (67%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Hematology & oncology specialists within 10 mi
63
Per 100K population
16.2
County median income
$81,194
Nearest hospital
FORT HAMILTON HUGHES MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lang is a mixed practice specialist, with above-average Medicare volume (top 10% in OH), with consulting-driven industry engagement in the top 14% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lang experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Lang performed 15,810 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lang receive payments from pharmaceutical companies?
Yes. Dr. Lang received a total of $48,732 from 48 companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lang's costs compare to other hematology & oncology specialists in Hamilton?
Dr. Lang's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Hamilton
Browse hematology & oncology specialists in Hamilton ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology